Rapid disease progression without seroconversion following primary human immunodeficiency virus type 1 infection - Evidence for highly susceptible human hosts

Journal of Infectious Diseases

Volumn 175, Issue 6, 1997, Pages 1352-1359

  Michael, Nelson L ^a   Brown, Arthur E ^c   Voigt, Robert F ^d   Frankel, Sarah S ^d   Mascola, John R ^d   Brothers, Karen S ^d   Louder, Mark ^d   Birx, Deborah L ^d   Cassol, Sharon A ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; DISEASE COURSE; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MALE; PRIORITY JOURNAL; SEROCONVERSION; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 0030973435     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/516467     Document Type: Article

References (14)

1. Tindall B, Cooper DA. Primary HIV infection: host responses and intervention strategies. AIDS 1991;5:1-14.
2. Imagawa DT, Lee MH, Wolinsky SM, et al. Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods. N Engl J Med 1989;320:1458-62.
3. Coutlee F, Olivier C, Cassol S, et al. Absence of prolonged immunosilent infection with human immunodeficiency virus in individuals with high-risk behaviors. Am J Med 1994;96:42-8.
4. Pan LZ, Sheppard HW, Winkelstein W, Levy JA. Lack of detection of human immunodeficiency virus in persistently seronegative homosexual men with high or medium risks for infection. J Infect Dis 1991;164: 962-4.
5. Ho DD, Moudgil T, Robin HS, Alam M, Wallace BJ, Mizrachi Y. Human immunodeficiency virus type l in a seronegative patient with visceral Kaposi's sarcoma and hypogammaglobulinemia. Am J Med 1989; 86: 349-51.
6. Busch MP, Lee LL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995;35:91-7.
7. Constantine NT, van der Groen G, Belsey EM, Tamashiro H. Sensitivity of HIV-antibody assays determined by seroconversion panels. AIDS 1994; 8:1715-20.
8. Martin-Rico P, Pedersen C, Skinhoj P, Nielsen C, Lindhardt BO. Rapid development of AIDS in an HIV-1 antibody-negative homosexual man. AIDS 1995;9:95-6.
9. Oka S, Ida S, Shioda T, et al. Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man. AIDS Res Hum Retroviruses 1994; 10:271-7.
10. Reimer L, Brokopp C, Mottice S, Den R, Nichols C. Persistent lack of detectable HIV-1 antibody in a person with HIV infection. MMWR Morb Mortal Wkly Rep 1996;45:181-5.
11. Soriano V, Dronda F, Gonzalez-Lopez A, et al. HIV-1 causing AIDS and death in a seronegative individual [letter]. Vox Sang 1994;67:410-1.
12. Wegner S, Ohl C, DeNobile J, et al. Case report of a woman with seronegative HIV-1 infection (abstract 173). AIDS Res Hum Retroviruses 1995; 11(suppl 1):S107.
13. Japour AJ, Fiscus SA, Arduino JM, Mayers DL, Reichelderfer PS, Kuritzkes DR. Standardized microtiter assay for determination of syncytiuminducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J Clin Microbiol 1994:32:2291-4.
14. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996:2:405-11.